Andrew Aromando

Insider Reports History

Location
La Jolla, CA
Signature
/s/ Kirk Look, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Aromando:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma, Inc. Chief Operating Officer Common Stock 109,263 $1,072,963 $9.82 11 Dec 2023 Direct
ONCOLYTICS BIOTECH INC Chief Business Officer Common Shares 25,500 $26,520 $1.04 01 Jan 2026 Direct
Ambrx Biopharma, Inc. Chief Operating Officer Restricted Stock Units 0 $0 $9.82 07 Mar 2024 Direct
Ambrx Biopharma Inc. Chief Operating Officer Stock Option (right to buy) 389,000 05 Jul 2023 Direct
Ambrx Biopharma, Inc. Chief Operating Officer Option to Purchase Common Stock 0 07 Mar 2024 Direct

Insider Reports Filed by Andrew Aromando

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ONCY ONCOLYTICS BIOTECH INC 01 Jan 2026 0 $0 3 Chief Business Officer 02 Jan 2026, 16:30
AMAM Ambrx Biopharma, Inc. 07 Mar 2024 3 $0 4 Chief Operating Officer 07 Mar 2024, 17:43
AMAM Ambrx Biopharma, Inc. 11 Dec 2023 1 $0 4 Chief Operating Officer 11 Dec 2023, 17:19
AMAM Ambrx Biopharma Inc. 05 Jul 2023 1 $0 4 Chief Operating Officer 07 Jul 2023, 16:05
AMAM Ambrx Biopharma Inc. 28 Apr 2023 1 $0 4 Chief Operating Officer 05 May 2023, 16:10
AMAM Ambrx Biopharma Inc. 28 Apr 2023 0 $0 3 Chief Operating Officer 05 May 2023, 16:05